Intact Vascular Secures $38.9 Million in Series B Financing to Accelerate Development of Endovascular Dissection Repair Technology – New Enterprise Associates leads Series B round and is joined by existing investors Quaker Partners and H.I.G. BioVentures, Proceeds to support expansion of Intact’s global clinical development program for the Tack Endovascular System™ platform technology

May 14, 2015 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it has raised $38.9 million in a Series B venture capital financing. The funds will be used to accelerate the development and FDA approval of the company’s Tack Endovascular System. The latest …

Intact Vascular Secures $38.9 Million in Series B Financing to Accelerate Development of Endovascular Dissection Repair Technology – New Enterprise Associates leads Series B round and is joined by existing investors Quaker Partners and H.I.G. BioVentures, Proceeds to support expansion of Intact’s global clinical development program for the Tack Endovascular System™ platform technology Read More »